Patents by Inventor Matthias Majetschak

Matthias Majetschak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BLOCKADE OF CHEMOKINE (C-C MOTIF) RECEPTOR 2 DURING FLUID RESUSCITATION
    Publication number: 20230270732
    Abstract: CCR2 is involved in the regulation of normal cardiovascular function and during the cardiovascular stress response to hemorrhagic shock and fluid resuscitation. Disclosed herein are methods of using CCR2 inhibitors to reduce fluid requirements and to prevent death from hemodynamic decompensation during resuscitation.
    Type: Application
    Filed: February 28, 2023
    Publication date: August 31, 2023
    Inventors: Matthias MAJETSCHAK, Anthony DESANTIS, Xianlong GAO
  • Methods of Treating Vascular Leakage Using CXCL12 Peptides
    Publication number: 20210052701
    Abstract: The present invention relates to methods for treatment of capillary leak syndrome and acute respiratory distress syndrome using CXCL12 peptides, specifically a constitutively monomeric CXCL12 peptide or a CXCL12 locked dimer polypeptide.
    Type: Application
    Filed: October 27, 2020
    Publication date: February 25, 2021
    Inventors: Brian F. Volkman, Matthias Majetschak, You-Hong Cheng
  • METHODS OF USING POTASSIUM CHANNEL INHIBITORS (BLOCKERS) FOR FLUID RESUSCITATION
    Publication number: 20170304281
    Abstract: Methods and pharmaceutical treatments of fluid resuscitation in which a selective potassium channel inhibitor is administered to a patient in a therapeutic amount sufficient to stabilize blood pressure and/or to reduce the amount of the resuscitation fluid otherwise required to resuscitate the patient.
    Type: Application
    Filed: April 19, 2017
    Publication date: October 26, 2017
    Inventors: Matthias Majetschak, Kenneth Lee Byron, Sean Patrick Nassoiy
  • UBIQUITIN AND UBIQUITIN RELATED MOLECULES FOR TREATMENT AND PREVENTION OF HARMFUL ACTIVATION OF THE IMMUNE SYSTEM
    Publication number: 20100160230
    Abstract: Compositions and methods for suppressing the immune system of a mammal using ubiquitin and derivatives and analogs thereof.
    Type: Application
    Filed: December 18, 2009
    Publication date: June 24, 2010
    Applicants: University of Heidelberg, University of Miami
    Inventors: Matthias Majetschak, Kenneth G. Proctor
  • Ubiquitin and ubiquitin related molecules for treatment and prevention of harmful activation of the immune system
    Publication number: 20070207162
    Abstract: Compositions and methods for suppressing the immune system of a mammal using ubiquitin and derivatives and analogs thereof
    Type: Application
    Filed: April 11, 2007
    Publication date: September 6, 2007
    Applicant: University of Miami
    Inventors: Matthias Majetschak, Kenneth Proctor
  • Ubiquitin and ubiquitin related molecules for treatment and prevention of harmful activation of the immune system
    Patent number: 7262162
    Abstract: Compositions and methods for suppressing the immune system of a mammal using ubiquitin and derivatives and analogs thereof.
    Type: Grant
    Filed: February 26, 2003
    Date of Patent: August 28, 2007
    Assignees: University of Heidelberg, University of Miami
    Inventors: Matthias Majetschak, Kenneth G. Proctor
  • Ubiquitin and ubiquitin related molecules for treatment and prevention of harmful activation of the immune system
    Publication number: 20040037822
    Abstract: Compositions and methods for suppressing the immune system of a mammal using ubiquitin and derivatives and analogs thereof
    Type: Application
    Filed: February 26, 2003
    Publication date: February 26, 2004
    Inventors: Matthias Majetschak, Kenneth G. Proctor